How Do You Get Diagnosed with Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 28, 2021 Category: General Medicine Source Type: news

VTE Risk Up for Children With Inflammatory Bowel Disease
Venous thromboembolism occurred less often for those with Crohn disease versus ulcerative colitis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 27, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pediatrics, Pharmacy, Journal, Source Type: news

VTE Risk Up for Children With Inflammatory Bowel Disease
TUESDAY, July 27, 2021 -- Children with inflammatory bowel disease (IBD) have a higher risk for venous thromboembolism (VTE), according to a study published online June 27 in the Journal of Crohn's& Colitis. M. Ellen Kuenzig, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2021 Category: Pharmaceuticals Source Type: news

Fifteen years in the making, biotech lands in Bay Area with fresh funding from Hyatt heirs and plan to change direction of inflammatory diseases
Giant drug maker Bristol-Myers Squibb and a string of investment vehicles led by heirs of the Hyatt Hotels fortune invested in a North Bay company tapping deep patient data to move faster to discover and develop drugs against lupus, Crohn's disease and other inflammatory diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 27, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Jeff Hordley health: Wife Zoe Henry opens up about soap star's lifelong health condition
JEFF HORDLEY, 51, is instantly recognisable as Cain Dingle in the ITV soap opera Emmerdale, but he has also made a name for himself as an ardent campaigner for Crohn's disease - a condition he has lived with for decades. A couple of years back, the soap star's wife Zoe Henry, 47, shed further light on his chronic condition. (Source: Daily Express - Health)
Source: Daily Express - Health - July 26, 2021 Category: Consumer Health News Source Type: news

Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study
Abstract Background Inflammatory bowel disease (IBD) has a significant impact on quality of life for many people. Objective To assess the prevalence of common mental health conditions in IBD and the combined impact of IBD and mental health conditions on healthcare use and time off work. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 26, 2021 Category: Consumer Health News Source Type: news

How Do You Diagnose Ulcerative Colitis?
Title: How Do You Diagnose Ulcerative Colitis?Category: Diseases and ConditionsCreated: 7/23/2021 12:00:00 AMLast Editorial Review: 7/23/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 23, 2021 Category: Nutrition Source Type: news

Cambridge microbiome startup's shares sliced in half after key trial failure
Microbiome startup Seres Therapeutics' shares are in a free fall after the company announced that its ulcerative colitis drug had failed in a mid-stage clinical trial. Seres (Nasdaq: MCRB) had been developing the drug in partnership with Nestlé Health Science as part of its suite of bacteria-based drugs, several of which are in clinical development. The ulcerative colitis study will be shut down, as the drug resulted in "no meaningful clinical differences" in a placebo comparison trial involving… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 22, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

Is Crohn's Disease Related to Rheumatoid Arthritis?
Title: Is Crohn's Disease Related to Rheumatoid Arthritis?Category: Diseases and ConditionsCreated: 7/20/2021 12:00:00 AMLast Editorial Review: 7/20/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 20, 2021 Category: Nutrition Source Type: news

Ultra-Processed Food May Up Risk for Inflammatory Bowel Disease
THURSDAY, July 15, 2021 -- A higher intake of ultra-processed food is associated with an increased risk for inflammatory bowel disease (IBD), according to a study published online July 14 in The BMJ. Neeraj Narula, M.D., M.P.H., from McMaster... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 15, 2021 Category: Pharmaceuticals Source Type: news

Ultra-Processed Foods Might Help Drive Inflammatory Bowel Disease
THURSDAY, July 15, 2021 -- If you need another reason to eat healthy, new research suggests that eating lots of packaged snacks and other ultra-processed foods could increase your risk of inflammatory bowel disease (IBD). Ultra-processed foods also... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 15, 2021 Category: General Medicine Source Type: news

Ultra-Processed Foods Might Help Drive Inflammatory Bowel Disease
Title: Ultra-Processed Foods Might Help Drive Inflammatory Bowel DiseaseCategory: Health NewsCreated: 7/15/2021 12:00:00 AMLast Editorial Review: 7/15/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 15, 2021 Category: Nutrition Source Type: news

MD Anderson research highlights for July 14, 2021
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a promising combination therapy for acute myeloid leukemia, understanding mechanisms driving resistance to PARP inhibitors, a therapeutic neoantigen vaccine to treat lung cancer, a novel treatment for triple-negative breast cancer and a new understanding of how telomeres may drive inflammatory bowel disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2021 Category: Cancer & Oncology Source Type: news

Can Crohn's Disease Be Cured With Surgery?
Title: Can Crohn's Disease Be Cured With Surgery?Category: Procedures and TestsCreated: 7/13/2021 12:00:00 AMLast Editorial Review: 7/13/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 13, 2021 Category: Nutrition Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

For pediatric patients with Crohn's disease, factors associated with statural growth differ by sex
(Weill Cornell Medicine) Growth impairment, a common complication of Crohn's disease in children, occurs more often in males than females, but the reasons are unclear. Now, a physician-scientist from Weill Cornell Medicine and NewYork-Presbyterian and colleagues at eight other centers have found that factors associated with statural growth differ by sex. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Adalimumab Safe and Effective in Children With Ulcerative Colitis Adalimumab Safe and Effective in Children With Ulcerative Colitis
Adalimumab is effective and well tolerated in children with moderate-to-severe ulcerative colitis, according to results of the ENVISION I study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 6, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

More efficient tests may one day replace endoscopy
(University of Houston) A University of Houston biomedical researcher is widening the net, looking for symptoms of other proteins -- not just blood - found elevated in colorectal cancer and inflammatory bowel disease. The new biomarkers may one day replace the invasive endoscopy to determine what's going on inside the intestines. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 29, 2021 Category: Biology Source Type: news

Contrast-Free Imaging Can Spot Postop Crohn's Recurrence Contrast-Free Imaging Can Spot Postop Crohn's Recurrence
For the diagnosis of postoperative recurrence of Crohn's disease at the anastomotic site, diffusion-weighted magnetic resonance enterography (MRE) is on par with contrast-enhanced MRE, report radiologists from France.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 28, 2021 Category: Radiology Tags: Gastroenterology News Source Type: news

Outcome After Anti-TNF Discontinuation in Patients With IBD Outcome After Anti-TNF Discontinuation in Patients With IBD
This study assessed the risk of relapse in the long-term after anti-TNF discontinuation in patients with inflammatory bowel disease. What factors were associated with a higher probability of relapse?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Risk for VTE Up for IBD Patients Infected With SARS-CoV-2
THURSDAY, June 24, 2021 -- Patients with inflammatory bowel disease (IBD) who contract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have a markedly increased risk for venous thromboembolism (VTE), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Ustekinumab in Infliximab-refractory Pediatric UC Ustekinumab in Infliximab-refractory Pediatric UC
This study evaluated the efficacy of ustekinumab following failure of prior biologics in pediatric ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Crohn ’s Disease vs Ulcerative Colitis Difference
Crohn ’s Disease vs. Ulcerative Colitis: What's the Difference? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 21, 2021 Category: General Medicine Source Type: news

What Is Life Expectancy with Ulcerative Colitis
What Is the Life Expectancy with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

What Is the Best Treatment for Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

What Were First Symptoms of Ulcerative Colitis
What Were Your First Symptoms of Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news

What Is the Life Expectancy of Ulcerative Colitis
What Is the Life Expectancy of Someone with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news

Guidelines: Management of Moderate to Severe Crohn's Disease Guidelines: Management of Moderate to Severe Crohn's Disease
The AGA released guidelines for adult outpatients with moderate to severe Crohn's disease, strongly recommending induction and maintenance therapy with anti-TNF-alpha agents or ustekinumab.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 16, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Risk for Adverse Events Not Increased After COVID-19 Vaccine in IBD
MONDAY, June 14, 2021 -- Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19 vaccination, according to a study published online May 25 in the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2021 Category: Pharmaceuticals Source Type: news

Kirigami-inspired stent offers new drug delivery method for tubular organs
(Brigham and Women's Hospital) To improve drug delivery for diseases that affect tubular organs, like eosinophilic esophagitis and inflammatory bowel disease, a multidisciplinary team from Brigham and Women's Hospital, Massachusetts General Hospital and Massachusetts Institute of Technology (MIT) designed a stretchable stent based on the principles of kirigami that is capable of supporting rapid deposition of drug depots. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

COVID Vaccines Appear Safe for People With IBD
THURSDAY, June 10, 2021 -- The Pfizer and Moderna COVID-19 vaccines appear to be safe for people with inflammatory bowel diseases (IBD), a new study finds. IBDs -- which includes Crohn's disease and ulcerative colitis -- are chronic conditions... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 10, 2021 Category: General Medicine Source Type: news

Diets Compared for Mild-to-Moderate Crohn Disease in Adults
WEDNESDAY, June 9, 2021 -- The specific carbohydrate diet (SCD) is not superior to the Mediterranean diet (MD) for the remission of symptoms in adults with mild-to-moderate Crohn disease (CD), according to a study published online May 26 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2021 Category: Pharmaceuticals Source Type: news

What Diet Is Most Likely to Help Ease Crohn's Disease?
Title: What Diet Is Most Likely to Help Ease Crohn's Disease?Category: Health NewsCreated: 6/8/2021 12:00:00 AMLast Editorial Review: 6/9/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 9, 2021 Category: Nutrition Source Type: news

What Diet Is Most Likely to Help Ease Crohn's Disease?
TUESDAY, June 8, 2021 -- People who have Crohn's disease often seek to ease their symptoms by changing what they eat, and new research suggests the Mediterranean diet may be their best bet. The study evaluated one of the commonly used diets for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 8, 2021 Category: General Medicine Source Type: news

AGA Issues Recommendations for Moderate-to-Severe Crohn Disease
FRIDAY, June 4, 2021 -- In clinical practice guidelines from the American Gastroenterological Association (AGA) published in the June 1 issue of Gastroenterology, recommendations are presented for the management of moderate-to-severe luminal and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2021 Category: Pharmaceuticals Source Type: news

What Are Best Foods to Eat with Crohn's Disease
What Are the Best Foods to Eat with Crohn's Disease? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

What Are the Warning Signs of Crohns Disease
What Are the Warning Signs of Crohn ’s Disease? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Association Between IBD and Migraine or Severe Headache Association Between IBD and Migraine or Severe Headache
Is migraine or severe headache more prevalent among US adults with inflammatory bowel disease than those without?Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 2, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

SEAVUE: Ustekinumab vs Adalimumab for Crohn's Disease SEAVUE: Ustekinumab vs Adalimumab for Crohn's Disease
For biologic-naive adults with moderate to severe Crohn's disease, treatment with either adalimumab or ustekinumab leads to similar outcomes, according to results of the head-to-head SEAVUE trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis
Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely active ulcerative colitis.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 28, 2021 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

'Good' bacteria show promise for clinical treatment of Crohn's disease, ulcerative colitis
(University of North Carolina Health Care) Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, is the senior author of a study that shows how a novel consortium of bacteria that live in the digestive tracts of healthy individuals can be used to prevent and treat aggressive colitis in humanized mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news

Guidelines Issued for Endoscopy of Surgically Altered Bowel
THURSDAY, May 27, 2021 -- In a consensus guideline issued by the Global Interventional Inflammatory Bowel Disease Group and published in the June 1 issue of The Lancet Gastroenterology& Hepatology, recommendations are presented for endoscopic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 27, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Bristol Myers Squibb ’s Zeposia (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
PRINCETON, N.J.--(BUSINESS WIRE) May 27, 2021 -- Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 27, 2021 Category: Drugs & Pharmacology Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn's VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn's
A study directly compares two biologic agents among patients with Crohn's disease who failed previous anti-TNF therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn's VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn's
A retrospective analysis compares two biologic agents among patients with Crohn's disease who failed previous anti-TNF therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

The 5 Goals of Colonoscopy in Ulcerative Colitis The 5 Goals of Colonoscopy in Ulcerative Colitis
Dr Stephen Hanauer remarks on ruling out mimics, establishing disease severity, surveilling for cancer, and other key reasons to perform routine colonoscopy.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Medicare Patients See Rising Rates of IBD Medicare Patients See Rising Rates of IBD
The prevalence of inflammatory bowel disease increased significantly among Americans aged 67 years and older from 2001 to 2018, based on data from more than 25 million Medicare beneficiaries.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 20, 2021 Category: Gastroenterology Tags: Internal Medicine News Source Type: news

IBD Rates Rising Among Medicare Patients IBD Rates Rising Among Medicare Patients
The prevalence of inflammatory bowel disease increased significantly among Americans aged 67 years and older from 2001 to 2018, based on data from more than 25 million Medicare beneficiaries.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2021 Category: Consumer Health News Tags: Internal Medicine News Source Type: news